Market Reviews

May 19, 2020

Orthopedics to Take Unprecedented Hit from COVID-19, Market Fundamentals Remain Strong

Orthopedics to Take Unprecedented Hit from COVID-19, Market Fundamentals Remain Strong
The underlying fundamentals of the orthopedic industry remain unchanged due to COVID-19. However, we should prepare for significant alterations in the market landscape as well as the ways that we interact with colleagues and customers.

Member-Only Content

SUBSCRIBE Login
September 20, 2019

Orthopedic Public Companies Grow 2.6% YoY in Quarter

Orthopedic Public Companies Grow 2.6% YoY in Quarter
The second quarter of 2019 brought incremental improvement over the first. Stryker and Medtronic saw revenue growth in the mid-single digits, Smith Nephew performed at 1.6% and DePuy Synthes and Zimmer Biomet experienced a year-over-year loss. Price pressure was a common theme in the quarter for many companies, as it offset some gains made from increased surgical volumes for the reporting period.

Member-Only Content

SUBSCRIBE Login
June 18, 2019

Orthopedic Sales in Line with Seasonal Expectations for 1Q19

Orthopedic Sales in Line with Seasonal Expectations for 1Q19
The first quarter of 2019 brought modest growth to the orthopedic market, as expected seasonal softness and more competition in digital surgery platforms slowed sales for some of the largest players. The 25 companies covered in this article had combined total orthopedic sales of $8.7 billion, growing just 1.1% versus the prior year. While the top two players, DePuy Synthes and Zimmer Biomet, both saw -2% growth, the quarter did feature strong performances by Medtronic (+5%) and Wright Medical (+16%) among the larger players.

Member-Only Content

SUBSCRIBE Login
June 15, 2019

Robotics Recap: Orthopedic Executives Remain Bullish

Robotics Recap: Orthopedic Executives Remain Bullish
The first quarter of 2019 was an active one for robotic and digital surgery developments. As adoption of digital surgery tools increases, leadership from joint replacement and spine companies indicate they have seen a direct sales benefit from upselling and product pull through.

Member-Only Content

SUBSCRIBE Login
May 22, 2019

Hip Joint Replacement Market Experiences 3% Growth

The global hip joint replacement market grew 3.2% in 2018 vs. 2017, reaching revenue of USD $7.6 billion. We project that the market will reach $8.9 billion by 2023. In this article, we'll dive deeper into 2018 performance from companies like Zimmer Biomet, Stryker, DePuy Synthes, Smith & Nephew, Medacta and DJO, and review results from 1Q19.
April 23, 2019

Orthopedic Industry Revenue Reaches $51 Billion in 2018

Orthopedic Industry Revenue Reaches $51 Billion in 2018
According to our estimates published in THE ORTHOPAEDIC INUSTRY ANNUAL REPORT, orthopedic industry revenue reached $51 billion worldwide in 2018 and grew 3.5% over 2017. Results were mixed among the largest companies as some stumbled operationally while others overperformed, due in part to early adoption of technology and entry into high-growth segments. Common strategic themes present in 2018 that will continue as part of the industry's narrative in 2019 and beyond include connected ecosystems of products, flagship technology (e.g. robotics), portfolio-wide pull through and a growing shift to outpatient procedures.

Member-Only Content

SUBSCRIBE Login
December 13, 2018

2018 Year in Review: Revenue Projections and Technology Trends

2018 Year in Review: Revenue Projections and Technology Trends
In November, we published our downloadable report, 2018 Revenue Projections: Companies Over $200 Million, for the 25 largest orthopaedic companies. Sales for these 25 companies account for ~80% of the worldwide orthopaedic market. We project that these companies will combine for $41 billion in 2018 revenue, +3% vs. 2017.

Member-Only Content

SUBSCRIBE Login